← Back to Search

MyStroke for Stroke Survivors

N/A
Waitlist Available
Led By Christopher G Favilla, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Admitted to hospital with clinical diagnosis of acute ischemic stroke (imaging confirmation not required)
At least 18 years old
Must not have
Severe aphasia (score of ≥2 on NIHSS item 9)
Ischemic stroke that is attributed to a surgical procedure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Summary

This trial aims to see if using personalized video-based education on strokes can help patients and the healthcare system. They want to know if this method can improve stroke knowledge, reduce the need for healthcare after discharge

Who is the study for?
This trial is for stroke survivors and their caregivers. Participants must have received standard education during hospitalization for a stroke. They should be able to complete surveys on discharge day, and at 7 and 90 days after leaving the hospital.
What is being tested?
Researchers are testing 'MyStroke', a personalized video-based educational platform, against standard stroke education. The study measures if this platform can boost stroke knowledge and reduce health system use post-discharge by comparing two groups: one with standard care, another with additional access to MyStroke.
What are the potential side effects?
Since 'MyStroke' is an educational tool rather than a medical treatment, there are no direct side effects associated with its use in the context of this clinical trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was hospitalized for a stroke that was not caused by bleeding in the brain.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe difficulty speaking or understanding speech.
Select...
I had a stroke caused by a surgery.
Select...
I am being discharged to a facility for extended medical care.
Select...
I am unable or unwilling to do virtual study visits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The Stroke Patient Education Retention (SPER) survey
Secondary outcome measures
Antithrombotic medication awareness
Emergency Department utilization
EuroQoL EQ-5D-5L
+7 more
Other outcome measures
Antithrombotic medication awareness (7 days)
EuroQoL EQ-5D-5L (7 days)
Patient satisfaction with stroke education (7 days)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MyStroke + standard stroke educationExperimental Treatment1 Intervention
Participants in this arm of the study will receive institutional standard stroke education in addition to access to MyStroke, a personalized video-based education platform. Each participant will receive their personalized page via email or SMS, as per their preference, and they will receive automated nudges to visit educational material after hospital discharge.
Group II: Standard stroke educationActive Control1 Intervention
Participants in this arm of the study will receive institutional standard stroke education during the course of the hospitalization, standardized across the 5 participating sites. Standard education consists of non-standardized verbal bedside education by the care team, a standardized stroke educational booklet, and standardized verbal instructions by the bedside nurse addressing stroke risk factors and medications.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,027 Previous Clinical Trials
42,885,125 Total Patients Enrolled
31 Trials studying Stroke
4,201 Patients Enrolled for Stroke
Christopher G Favilla, MDPrincipal InvestigatorAssistant Professor of Neurology at the University of Pennsylvania
~391 spots leftby Mar 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top